The clinical study to explore the effects of SGLT2-inhibitors or DPP-4 inhibitors in Japanese patients with type 2 diabetes.
Not Applicable
Recruiting
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000020984
- Lead Sponsor
- Showa University School of Medicine, Division of Diabetes and Endocrinology, Department of Internal Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who are acute disease 2.Patients who are past history of hypersensitivity to anagliptin 3.Pregnant or woman of child-bearing potential 4.Patients whose eGFR are within 60mL/min/1.73m2 5.Patients who are judged as inappropriate for inclusion by phsicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method